Skip to main content Accessibility help

The Costs of Treating Breast Cancer in the United Kingdom: Implications for Screening

  • Jane L. Wolstenholme (a1), Sarah J. Smith (a1) and David K. Whynes (a1)


Total treatment costs by stage at diagnosis are estimated for a sample of breast cancer patients. At 4 years, stage 4 cancers emerge as being more expensive to treat than those at earlier stages, although this difference fails to achieve significance when expected lifetime costs are considered. The inclusion of treatment cost estimates in a screening model indicates that screening may increase expected treatment costs by a marginal amount, although the model also suggests that the cost effectiveness ratio of breast cancer screening might be better than had originally been thought.



Hide All
1.Atherton, L.The costs of radiotherapy treatments on a linear accelerator. British Journal of Radiology, 1984, 57, 106–07.
2.Balch, C. M., Singletary, S. E., & Bland, K. I.Clinical decision making in early breast cancer. Annals of Surgery, 1993, 217, 207–25.
3.Barsky, A. J.The paradox of health. New England Journal of Medicine, 1988, 318, 414–18.
4.Baum, M.Breast cancer: the facts. Oxford: Oxford University Press, 1988.
5.Brown, M. L., & Fintor, L.Cost effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature. Breast Cancer Research and Treatment, 1993, 25, 113–18.
6.Butler, J. R. G., Furnival, C. M., & Hart, R. F. G.Estimating treatment cost functions for progressive diseases: A multiproduct approach with an application to breast cancer. Journal of Health Economics, 1995, 14, 361–85.
7.Crisp, W. J., Higgs, M. J., Cowan, W. K., et al. Screening for breast cancer detects tumours at an earlier biological stage. British Journal of Surgery, 1993, 273, 142–47. Koning, H. J., van Ineveld, B. M., de Haes, J. C. J. M., et al. Advanced breast cancer and its prevention by screening. British Journal of Cancer, 1992, 65, 950–55.
9.Department of Health. Breast cancer screening 1991: Evidence and experience since the Forrest Report. Sheffield: NHS Breast Screening Program, 1991.
10.Department of Health and Social Security. Breast cancer screening: Report of a working group (Sir Patrick Forrest, Chairman) to the Health Ministers of England, Wales, Scotland and Northern Ireland., London: HMSO, 1986.
11.Dixon, J. M., & Mansel, R. E.Symptoms assessment and guidelines for referral. British Medical Journal, 1994, 309, 722–26.
12.Dixon, M., & Sainsbury, R.Handbook of diseases of the breast. Cambridge: Churchill Livingstone, 1993.
13.Finkler, S. A.The distinction between costs and charges. Annals of Internal Medicine, 1982, 96,102–09.
14.Goddard, M., & Hutton, J.The costs of radiotherapy in cancer treatment. Discussion paper 48. University of York: Centre for Health Economics, 1988.
15.Goddard, M., Maher, E. J., Hutton, J., et al. Palliative radiotherapy: Counting the costs of changing practice. Health Policy, 1991, 17, 243–56.
16.Gravelle, H., Simpson, P. R., & Chamberlain, J. O.Breast cancer screening and health service costs. Journal of Health Economics, 1982, 1, 185207.
17.Green, D.The cost of radiotherapy treatments on a linear accelerator. British Journal of Radiology, 1983, 56, 189–91.
18.Hill, F., & Oliver, C.Hospice: The cost of inpatient care. Health Trends, 1984,16, 911.
19.Jardines, L., Callans, L. S., & Torosian, M. H.Recurrent breast cancer: Presentation, diagnosis and treatment. Seminars in Oncology, 1993, 20, 538–47.
20.King’s Fund Forum Consensus development conference: Treatment of primary breast cancer. British Medical Journal, 1986, 293, 946–47.
21.Legorreta, A. P., Brooks, R. J., Leibowitz, A. N., et al. Cost of breast cancer treatment. Archives of Internal Medicine, 1996, 156, 2197–201.
22.Leonard, R. C. F., Rodger, A., & Dixon, J. M.Metastatic breast cancer. British Medical Journal, 1994, 309, 1501–04.
23.Moody, C., Corder, A., Mullee, M. A., et al. The impact of the first 3 years of breast cancer screening on the overall presentation of breast cancer. Journal of the Royal Society of Medicine, 1994, 87, 259–62.
24.Olson, J. A.On what basis should health be discounted? Journal of Health Economics, 1993, 12, 3953.
25.Rees, G. J. G.Cost-effectiveness in oncology. Lancet, 1985, ii, 1405–07.
26.Richards, M. A., Braysher, S., Gregory, W. M., et al. Advanced breast cancer: Use of resources and cost implications. British Journal of Cancer, 1993, 67, 856–60.
27.Robertson, F. M., Romanow, J., & Otchy, D. P.Effect of mass screening mammography on staging of carcinoma of the breast in women. Surgery: Gynecology and Obstetrics, 1990, 171, 5558.
28.Robertson, J. R. F., Whynes, D. K., Dixon, A., et al. Potential for cost economies in guiding patients with metastatic breast cancer. British Journal of Cancer, 1995, 72, 174–77.
29.Rodger, A., Leonard, R. C. F. & Dixon, J. M.Locally advanced breast cancer. British Medical Journal, 1994, 309, 1431–33.
30.Rodgers, A.The UK breast cancer screening program: An expensive mistake. Journal of Public Health Medicine, 1990, 12, 197204.
31.Rubens, R. D.Management of early breast cancer. British Medical Journal, 1992, 304, 1361–64.
32.Rubens, R. D.The management of locally advanced breast cancer. British Journal of Cancer, 1992, 65, 145–47.
33.Salkeld, G., & Gerard, K.Will early detection of breast cancer reduce the costs of treatment? Australian Journal of Public Health, 1994, 18, 388–93.
34.Screening brief: Breast cancer [editorial] Journal of Medical Screening, 1994, 1, 73.
36.U.K. Trial of Early Detection of Breast Cancer Group. Breast cancer mortality after 10 years in the UK trial of early detection of breast cancer. The Breast, 1993, 2, 1320.
35.Sculpher, M. J., & Buxton, M. J.The private costs incurred when patients attend screening clinics: The cases of screening for breast cancer and for diabetic retinopathy. Uxbridge. Brunel University, Health Economics Research Group, 1993.
37.Warren, R., & Skrabanek, P.The debate over mass mammography in Britain: The case for, the case against. British Medical Journal, 1988, 297, 969–72.
38.Watson, J. M. G., & Junger, G.Principles and Practice of Screening for Disease: WHO Public Health Papers 34. Geneva: WHO, 1968.
39.Whynes, D. K., Walker, A. R., Chamberlain, J. O., et al. Screening and the costs of treating colorectal cancer. British Journal of Cancer, 1993, 68, 965–68.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed